Fact CheckerSign in

NCT07465783Recruiting

Effects of Musical Intervention by a Therapist (IMT) on Falling Asleep and Behavioral Regulation in a Secure Care Unit (SCU)

Effects of Musical Intervention by a Therapist (IMT) on Falling Asleep and Behavioral Regulation in a Secure Care Unit (SCU) Pilot Study

Source: ClinicalTrials.gov · Last updated 3 Aug 2026

Brief summary (registry, in English)

This is a prospective, multicenter study designed to evaluate the benefits of an evening music-based intervention on sundowning syndrome in patients with Alzheimer's disease or related disorders in a Protect lLife Unit setting.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
48 (estimated)
First submitted
21 Jan 2026
Start date
2 Feb 2026
Primary completion date
Jul 2027
Lead sponsor
Centre Hospitalier Universitaire de Saint Etienne
NCT number
NCT07465783

What you commit to

  • Study type: Interventional
  • Planned participants: 48
  • From 2 Feb 2026 to the primary completion date, Jul 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Participation in a study on a drug/medical device/treatment technique that may affect sleep or behavior.

Other

  • Refusal to participate
  • Highly sedated patients,
  • Patients with acute medical instability,
  • Patients with productive delusions,
  • Patients who have been in the unit for less than 1 month

Who the study is looking for

  • Signature of consent by the patient's legal guardian obtained after providing information
  • Patients aged 60 and over who meet the diagnostic criteria for Alzheimer's disease and related disorders, including mainly: Lewy body disease, frontotemporal lobar degeneration, progressive supranuclear palsy, corticobasal degeneration, vascular encephalopathy, alcoholic dementia, primary progressive aphasia syndrome, posterior cortical atrophy syndrome (France Alzheimer, 2024).
  • Patient living in a secure care unit
  • If taking psychotropic drugs, they must have been stable for 3 months
  • If taking level 2 or 3 painkillers, they must have been stable for 1 month

Age in the registry: 60 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Saint-etienne hospital
Coordinator of this site? Confirm its status
Saint-EtienneFranceRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.